Jeonjinbio Co., Ltd. (KOSDAQ:110020)

Jeonjinbio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,684	6,276	1,692	1,334	15,306	8,922
Short-Term Investments	-	472.52	1,494	-	-	-
Cash & Short-Term Investments	5,684	6,748	3,187	1,334	15,306	8,922
Cash Growth	-6.60%	111.78%	138.79%	-91.28%	71.54%	114.37%
Accounts Receivable	2,718	2,452	2,803	724.02	205.04	93.8
Other Receivables	7.65	2.82	5.42	5.98	4.15	87.22
Receivables	2,725	2,455	2,808	1,330	209.19	181.02
Inventory	1,262	921.32	1,746	1,982	602.35	341.57
Prepaid Expenses	10.89	6.04	8.07	57.1	7.76	285.1
Other Current Assets	141.94	14.03	17.24	52.83	33.04	256.87
Total Current Assets	9,824	10,144	7,767	4,756	16,158	9,987
Property, Plant & Equipment	9,157	8,687	9,765	10,948	7,997	8,048
Long-Term Investments	-	-	-	-0	-0	0
Other Intangible Assets	15.36	21.76	71.88	80.62	58.36	72.7
Long-Term Deferred Charges	-	-	-	636.91	552.08	488.95
Other Long-Term Assets	0.2	0.2	100.28	1,503	52.32	98.03
Total Assets	18,997	18,853	17,704	17,924	24,817	18,695
Accounts Payable	183.32	260.14	239.75	139.18	47.85	19.95
Accrued Expenses	619	445.89	521.74	485.06	337.31	321.58
Short-Term Debt	-	-	5,309	4,583	7,401	-
Current Portion of Long-Term Debt	-	-	-	-	-	5,107
Current Portion of Leases	-	92.62	288.27	1,089	7.5	31.38
Other Current Liabilities	317.9	287.53	4,854	1,651	6,185	1,863
Total Current Liabilities	1,120	1,086	11,213	7,947	13,979	7,343
Long-Term Leases	-	-	-	288.27	-	7.04
Pension & Post-Retirement Benefits	152.56	105.69	227.73	60.19	1.17	-
Other Long-Term Liabilities	-0	-	43.52	63.44	41.17	63
Total Liabilities	1,273	1,192	11,484	8,359	14,022	7,413
Common Stock	4,529	4,529	3,742	3,420	3,171	3,021
Additional Paid-In Capital	42,313	42,313	35,585	32,955	31,407	29,911
Retained Earnings	-28,029	-28,092	-32,419	-25,900	-22,872	-20,746
Comprehensive Income & Other	-1,089	-1,089	-688.68	-910.12	-910.12	-904.91
Total Common Equity	17,724	17,661	6,220	9,565	10,796	11,282
Shareholders' Equity	17,724	17,661	6,220	9,565	10,796	11,282
Total Liabilities & Equity	18,997	18,853	17,704	17,924	24,817	18,695
Total Debt	-	92.62	5,597	5,960	7,409	5,146
Net Cash (Debt)	5,684	6,656	-2,410	-4,625	7,897	3,777
Net Cash Growth	-0.64%	-	-	-	109.09%	160.63%
Net Cash Per Share	632.03	773.80	-330.86	-702.78	1273.53	774.52
Filing Date Shares Outstanding	8.98	9.06	7.48	6.84	6.34	6.04
Total Common Shares Outstanding	8.98	9.06	7.48	6.84	6.34	6.04
Working Capital	8,704	9,058	-3,446	-3,191	2,179	2,644
Book Value Per Share	1974.13	1949.65	831.11	1398.45	1702.42	1867.27
Tangible Book Value	17,709	17,640	6,148	9,485	10,737	11,209
Tangible Book Value Per Share	1972.42	1947.25	821.51	1386.67	1693.21	1855.23
Land	-	3,041	3,041	3,041	3,041	3,041
Buildings	-	3,568	3,568	3,568	3,568	3,568
Machinery	-	3,194	3,008	2,206	1,565	1,265
Construction In Progress	-	78	268	545.59	-	221.91

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.